RecruitingNot ApplicableNCT07631286
Ejaculatory-Sparing HoLEP vs Standard HoLEP
Ejaculatory-sparing Holmium Laser Enucleation of the Prostate (HoLEP) vs Standard HoLEP: a Randomized Controlled Trial
Sponsor
Northwestern University
Enrollment
48 participants
Start Date
Jun 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this study is to compare a new surgical technique for HoLEP that will allow for sparing of ejaculation post-HoLEP.
Eligibility
Sex: MALEMin Age: 18 YearsMax Age: 100 Years
Inclusion Criteria1
- \- Patients who are sexually active with antegrade ejaculation who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms.
Exclusion Criteria5
- Patients with pre-existing retrograde ejaculation
- Patients who are not sexually active
- Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic/urethral surgery that may impact ejaculation
- Patients who lack decisional capacity
- Patients unable to read/speak English
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHEREjaculatory-sparing (ES-sparing) HoLEP
The ejaculatory sparing technique involves sparing the distal apex of the prostate in particular the anterior portion of the prostate which will allow for coaptation necessary for antegrade ejaculation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07631286
Related Trials
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
NCT076327421 location
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
NCT064911081 location
Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)
NCT053305202 locations